{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:34:00Z","timestamp":1785803640390,"version":"3.56.0"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Autism spectrum disorder (ASD) is rising in prevalence, but effective treatments for its core symptoms remain limited. Fecal microbiota transplantation (FMT) has shown promise; however, conventional methods often require antibiotics and bowel cleansing, raising concerns regarding safety and sustainability. We developed a novel FMT method using hydrogen nanobubble water and investigated its efficacy and safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This prospective, single-arm, before-and-after comparative study enrolled 30 children aged 5\u201312 years with ASD, selected according to inclusion and exclusion criteria. SHIN-1, a Good Manufacturing Practice (GMP)-grade prepared fecal microbial solution from a healthy screened donor, was suspended in hydrogen nanobubble water and administered via enema. Primary outcome was the Social Responsiveness Scale-2 (SRS-2), with objectivity confirmed using Gazefinder as an eye-tracking system. Secondary outcomes included sensory profile [Short Sensory Profile (SSP)], gastrointestinal symptoms [Gastrointestinal Symptom Rating Scale [GSRS], Bristol Stool Form Scale [BSFS]] and Patient Health Questionnaire-4 items (PHQ-4). Statistical analyses employed paired t-tests or Wilcoxon signed-rank tests (\n                      <jats:italic>\u03b1<\/jats:italic>\n                      \u2009=\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At 30 weeks, fecal microbiota reconstitution was observed, with increases in short-chain fatty acid\u2013producing and typically taxa abundant in developing children. SRS-2 scores decreased 29% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), sustained at one year. The classification is as follows; 19 severe cases improved to mild and 6 to normal. Improvements were greater in children without gastrointestinal disorders (45% vs. 24%). Social Communication and Interaction (SCI), Restricted Interests and Repetitive Behavior (RRB), and subscales improved uniformly; sensory, gastrointestinal, and emotional symptoms improved by 30%\u201361%. No adverse events occurred.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This novel hydrogen nanobubble water\u2013based FMT method was safe and effective, reducing both core and peripheral symptoms of ASD and suggesting broad benefits via the gut microbiota\u2013brain axis.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Clinical Trial Registration:<\/jats:bold>\n                      <jats:ext-link>https:\/\/jrct.mhlw.go.jp\/en-latest-detail\/jRCTs031230041<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1767346","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:50:47Z","timestamp":1773211847000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Safety and efficacy of a novel fecal microbiota transplantation method using hydrogen nanobubble water without antibiotics or bowel cleansing in children with autism spectrum disorder: an open-label, single-arm study demonstrating improvements in core and comorbidity symptoms"],"prefix":"10.3389","volume":"14","author":[{"given":"Masahiko","family":"Shirotani","sequence":"first","affiliation":[{"name":"The Association for Clinical Research of Fecal Microbiota Transplantation Japan","place":["Osaka, Japan"]},{"name":"Shirotani Biowellness Clinic","place":["Hyogo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Shimizu","sequence":"additional","affiliation":[{"name":"The Association for Clinical Research of Fecal Microbiota Transplantation Japan","place":["Osaka, Japan"]},{"name":"Shinbiosis Corporation","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Kitamura","sequence":"additional","affiliation":[{"name":"The Association for Clinical Research of Fecal Microbiota Transplantation Japan","place":["Osaka, Japan"]},{"name":"Kiwakai Kitamura Clinic","place":["Fukuoka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Mikawa","sequence":"additional","affiliation":[{"name":"The Association for Clinical Research of Fecal Microbiota Transplantation Japan","place":["Osaka, Japan"]},{"name":"Natural Art Clinic Yotsuya","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Haruna","sequence":"additional","affiliation":[{"name":"The Association for Clinical Research of Fecal Microbiota Transplantation Japan","place":["Osaka, Japan"]},{"name":"Haruna Clinic","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Kawai","sequence":"additional","affiliation":[{"name":"The Association for Clinical Research of Fecal Microbiota Transplantation Japan","place":["Osaka, Japan"]},{"name":"Yuakai Kawai Clinic for Internal Medicine","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Koide","sequence":"additional","affiliation":[{"name":"The Association for Clinical Research of Fecal Microbiota Transplantation Japan","place":["Osaka, Japan"]},{"name":"Koide Clinic","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Mohri","sequence":"additional","affiliation":[{"name":"Department of Child Development, Course of Developmental Neuroscience, United Graduate School of Child Development, The University of Osaka","place":["Suita, Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Matsuzaki","sequence":"additional","affiliation":[{"name":"Research Center for Child Mental Development, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji J.","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Department of Child Development, Course of Developmental Neuroscience, United Graduate School of Child Development, The University of Osaka","place":["Suita, Osaka, Japan"]},{"name":"Research Center for Child Mental Development, Hamamatsu University School of Medicine","place":["Shizuoka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"The Association for Clinical Research of Fecal Microbiota Transplantation Japan","place":["Osaka, Japan"]},{"name":"Jinzenkai Tanaka Clinic","place":["Osaka-shi, Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiichi","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Child Development, Course of Developmental Neuroscience, United Graduate School of Child Development, The University of Osaka","place":["Suita, Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"B1","year":""},{"key":"B2","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.21037\/tp.2019.09.09","article-title":"Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation","volume":"9","author":"Hodges","year":"2020","journal-title":"Transl Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s42003-019-0558-4","article-title":"Social and non-social autism symptoms and trait domains are genetically dissociable","volume":"2","author":"Warrier","year":"2019","journal-title":"Commun Biol"},{"key":"B4","year":""},{"key":"B5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/1471-244X-14-189","article-title":"A randomized controlled study of a social skills training for children with autism spectrum disorders","volume":"14","author":"Dekker","year":"2014","journal-title":"BMC Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"CD009260","DOI":"10.1002\/14651858.CD009260.pub3","article-title":"Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD)","volume":"2018","author":"Reichow","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1176\/appi.ajp.162.6.1142","article-title":"Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology","volume":"162","author":"McDougle","year":"2005","journal-title":"Am J Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40265-013-0021-7","article-title":"Pharmacotherapy for the core symptoms in autistic disorder: current status of the research","volume":"73","author":"Farmer","year":"2013","journal-title":"Drugs"},{"key":"B9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/jcpp.13156","article-title":"Annual research review: critical windows\u2014the microbiota-gut-brain axis in neurocognitive development","volume":"61","author":"Cowan","year":"2020","journal-title":"J Child Psychol Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"8460","DOI":"10.3390\/ijms24108460","article-title":"The Microbiota\u2013gut\u2013brain axis in behaviour and brain disorders","volume":"24","author":"Lana","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e00331","DOI":"10.1128\/spectrum.00331-22","article-title":"Leveraging existing 16SrRNA microbial data to define a composite biomarker for autism spectrum disorder","volume":"10","author":"Xu","year":"2022","journal-title":"Am Soc Microbiol Microbiol Spectr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/mp.2013.65","article-title":"Microbiota is essential for social development in the mouse","volume":"19","author":"Desbonnet","year":"2014","journal-title":"Mol Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.cell.2019.12.025","article-title":"Establishing or exaggerating causality for the gut microbiome: lessons from human microbiota associated rodents","volume":"180","author":"Walter","year":"2020","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s40168-018-0523-3","article-title":"A prebiotic intervention study in children with autism spectrum disorders (ASDs)","volume":"6","author":"Grimaldi","year":"2018","journal-title":"Microbiome"},{"key":"B15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/medicina55050129","article-title":"A systematic review of the role of prebiotics and probiotics in autism spectrum disorders","volume":"55","author":"Ng","year":"2019","journal-title":"Medicina (B Aires)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/088307380001500701","article-title":"Short-term benefit from oral vancomycin treatment of regressive-onset autism","volume":"15","author":"Sandler","year":"2000","journal-title":"J Child Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1038\/s41598-019-42183-0","article-title":"Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota","volume":"9","author":"Kang","year":"2019","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"759435","DOI":"10.3389\/fcimb.2021.759435","article-title":"Fecal microbiota transplantation relieves gastrointestinal and autism symptoms by improving the gut microbiota in an open-label study","volume":"11","author":"Li","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1648471","DOI":"10.3389\/fped.2025.1648471","article-title":"Gut microbiota characteristics and therapeutic effects of fecal microbiota transplantation in children with autism spectrum disorder in central China: a combined cross-sectional and prospective study","volume":"13","author":"Wu","year":"2025","journal-title":"Front Pediatr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.3390\/nu13103326","article-title":"Nutrition and cancer risk from the viewpoint of the intestinal microbiome","volume":"13","author":"Tanaka","year":"2021","journal-title":"Nutrients"},{"key":"B21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.31989\/bchd.v3i8.735","article-title":"Ultrafine bubble water usefulness in fecal microbiota transplantation: recognition of transplanted microbiota in intestinal epithelial cells","volume":"3","author":"Shimizu","year":"2020","journal-title":"Bioact Compd Health Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e219234","DOI":"10.1001\/jamanetworkopen.2021.9234","article-title":"Trends in autism spectrum disorder diagnoses in Japan, 2009 to 2019","volume":"4","author":"Sasayama","year":"2021","journal-title":"JAMA Network Open"},{"key":"B23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10803-010-1024-9","article-title":"Autistic traits and autism spectrum disorders: the clinical validity of two measures presuming a continuum of social communication skills","volume":"41","author":"B\u00f6lte","year":"2011","journal-title":"J Autism Dev Disord"},{"key":"B24","doi-asserted-by":"publisher","first-page":"103395","DOI":"10.1016\/j.ajp.2022.103395","article-title":"Investigating and comparing the psychometric properties of the Chinese mandarin version of social responsiveness scale-2 and its shortened version in preschool-age children with autism spectrum disorder","volume":"79","author":"Yang","year":"2023","journal-title":"Asian J Psychiatr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.1038\/s41598-024-55643-z","article-title":"Feasibility of a 2-minute eye-tracking protocol to support the early identification of autism","volume":"14","author":"Chetcuti","year":"2024","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1250763","DOI":"10.3389\/fpsyt.2023.1250763","article-title":"Autism symptoms, functional impairments, and gaze fixation measured using an eye-tracker in 6-year-old children","volume":"14","author":"Mori","year":"2023","journal-title":"Front Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13229-016-0083-y","article-title":"Gazefinder as a clinical supplementary tool for discriminating between autism spectrum disorder and typical development in male adolescents and adults","volume":"7","author":"Fujioka","year":"2016","journal-title":"Mol Autism"},{"key":"B28","doi-asserted-by":"publisher","first-page":"603085","DOI":"10.3389\/fneur.2020.603085","article-title":"Diagnosing autism spectrum disorder without expertise: a pilot study of 5- to 17-year-old individuals using Gazefinder","volume":"11","author":"Tsuchiya","year":"2021","journal-title":"Front Neurol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jad.2009.06.019","article-title":"A 4-item measure of depression and anxiety: validation and standardization of the patient health questionnaire-4 (PHQ-4) in the general population","volume":"122","author":"L\u00f6we","year":"2010","journal-title":"J Affect Disord"},{"key":"B30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40168-016-0225-7","article-title":"Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study","volume":"5","author":"Kang","year":"2017","journal-title":"Microbiome"},{"key":"B31","author":"L\u00e9zard","year":""},{"key":"B32","author":"Sulkes","year":""},{"key":"B33","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrn3346","article-title":"Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour","volume":"13","author":"Cryan","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3389\/fpsyt.2019.00473","article-title":"Association between gut microbiota and autism spectrum disorder: a systematic review and meta analysis","volume":"10","author":"Xu","year":"2019","journal-title":"Front Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"630052","DOI":"10.3389\/fcimb.2021.630052","article-title":"Future directions in reducing gastrointestinal disorders in children with ASD using fecal microbiota transplantation","volume":"11","author":"\u017bebrowska","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jtcme.2022.03.001","article-title":"Gut microbiota and autism spectrum disorder: from pathogenesis to potential therapeutic perspectives","volume":"13","author":"Mehra","year":"2023","journal-title":"J Tradit Complement Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","article-title":"The gut microbiota\u2013brain axis in behaviour and brain disorders","volume":"19","author":"Morais","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.3390\/nu13124497","article-title":"The brain-gut-microbiome system: pathways and implications for autism spectrum disorder","volume":"13","author":"Chernikova","year":"2021","journal-title":"Nutrients"},{"key":"B39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13229-020-00321-w","article-title":"Developmental changes in attention to social information from childhood to adolescence in autism spectrum disorders: a comparative study","volume":"11","author":"Fujioka","year":"2020","journal-title":"Mol Autism"},{"key":"B40","doi-asserted-by":"publisher","first-page":"48R","DOI":"10.1203\/PDR.0b013e3182130c54","article-title":"Sensory processing in autism: a review of neurophysiologic findings","volume":"69","author":"Marco","year":"2011","journal-title":"Pediatr Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3389\/fpsyt.2019.01016","article-title":"Sensory abnormalities in autism spectrum disorders: a focus on the tactile domain, from genetic mouse models to the clinic","volume":"10","author":"Balasco","year":"2020","journal-title":"Front Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","first-page":"7201190010p1","DOI":"10.5014\/ajot.2018.028431","article-title":"Efficacy of occupational therapy using ayres sensory integration\u00ae: a systematic review","volume":"72","author":"Schaaf","year":"2018","journal-title":"Am J Occup Ther"},{"key":"B43","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10803-023-06228-8","article-title":"Psychiatric features of children with chronic functional constipation: focusing on individuals with autism spectrum disorder","volume":"55","author":"Akama","year":"2025","journal-title":"J Autism Dev Disord"},{"key":"B44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10802-012-9668-x","article-title":"Anxiety, sensory over-responsivity, and gastrointestinal problems in children with autism spectrum disorders","volume":"41","author":"Mazurek","year":"2013","journal-title":"J Abnorm Child Psychol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s10620-020-06133-5","article-title":"Autism spectrum disorder as a brain-gut-microbiome axis disorder","volume":"65","author":"Saurman","year":"2020","journal-title":"Dig Dis Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11596-019-2016-4","article-title":"Probiotic therapy for treating behavioral and gastrointestinal symptoms in autism spectrum disorder: a systematic review of clinical trials","volume":"39","author":"Liu","year":"2019","journal-title":"Curr Med Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.rpsm.2020.06.002","article-title":"Prebiotics, probiotics and fecal microbiota transplantation in autism: a systematic review","volume":"13","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2020","journal-title":"Rev Psiquiatr Salud Ment"},{"key":"B49","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","article-title":"Autism","volume":"383","author":"Lai","year":"2014","journal-title":"Lancet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnhum.2017.00020","article-title":"Sensory, emotional and cognitive contributions to anxiety in autism spectrum disorders","volume":"11","author":"South","year":"2017","journal-title":"Front Hum Neurosci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.95907","article-title":"Safety and potential risks with fecal microbiota transplantation","volume":"1","author":"Gaonkar","year":"2021","journal-title":"Contemp Top Patient Saf"},{"key":"B52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/apt.16148","article-title":"Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020","volume":"53","author":"Marcella","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"B53","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/pch\/pxz117","article-title":"Standards of diagnostic assessment for autism spectrum disorder","volume":"24","author":"Brian","year":"2019","journal-title":"Paediatr Child Health"},{"key":"B54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mSphere.00314-20","article-title":"Distinct fecal and plasma metabolites in children with autism spectrum disorders and their modulation after microbiota transfer therapy","volume":"5","author":"Kang","year":"2020","journal-title":"mSphere"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e0210064","DOI":"10.1371\/journal.pone.0210064","article-title":"Pilot study of probiotic\/colostrum supplementation on gut function in children with autism and gastrointestinal symptoms","volume":"14","author":"Sanctuary","year":"2019","journal-title":"PLoS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.bbi.2018.03.025","article-title":"Differential immune responses and microbiota profiles in children with autism spectrum disorders and co-morbid gastrointestinal symptoms","volume":"70","author":"Rose","year":"2018","journal-title":"Brain Behav Immun"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/nu14071471","article-title":"Gastrointestinal symptoms in autism spectrum disorder: a systematic review","volume":"14","author":"Leader","year":"2022","journal-title":"Nutrients"},{"key":"B58","doi-asserted-by":"publisher","first-page":"6540","DOI":"10.1523\/JNEUROSCI.2831-18.2019","article-title":"A neuroanatomical substrate linking perceptual stability to cognitive rigidity in autism","volume":"39","author":"Watanabe","year":"2019","journal-title":"J Neurosci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1038\/emm.2017.246","article-title":"Hydrogen-water ameliorates radiation-induced gastrointestinal toxicity via MyD88\u2019s effects on the gut microbiota","volume":"50","author":"Xiao","year":"2018","journal-title":"Exp Mol Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/SHK.0000000000001098","article-title":"Hydrogen-rich saline regulates intestinal barrier dysfunction, dysbiosis, and bacterial translocation in a murine model of sepsis","volume":"50","author":"Ikeda","year":"2018","journal-title":"Shock"},{"key":"B61","doi-asserted-by":"publisher","first-page":"104360","DOI":"10.1016\/j.jff.2021.104360","article-title":"Hydrogen-rich water as a modulator of gut microbiota?","volume":"78","author":"Ostojic","year":"2021","journal-title":"J Funct Foods"},{"key":"B62","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2147\/JIR.S445152","article-title":"Hydrogen regulates ulcerative colitis by affecting the intestinal redox environment","volume":"17","author":"Li","year":"2024","journal-title":"J Inflamm Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1016\/j.jpedsurg.2020.01.061","article-title":"Hydrogen-rich saline protects intestinal epithelial tight junction barrier in rats with intestinal ischemia-reperfusion injury by inhibiting endoplasmic reticulum stress-induced apoptosis pathway","volume":"55","author":"Jiang","year":"2020","journal-title":"J Pediatr Surg"},{"key":"B64","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4265\/bio.27.139","article-title":"Evaluation of bactericidal effects of H","volume":"27","author":"Morishita","year":"2022","journal-title":"Biocontrol Sci"},{"key":"B65","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.msec.2015.03.064","article-title":"Antioxidant activities of nano-bubble hydrogen-dissolved water assessed by ESR and 2,2'-bipyridyl methods","volume":"53","author":"Kato","year":"2015","journal-title":"Mater Sci Eng C Mater Biol Appl"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1767346\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:50:48Z","timestamp":1773211848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1767346\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":65,"alternative-id":["10.3389\/fped.2026.1767346"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1767346","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"article-number":"1767346"}}